Posted by Francis on July 8, 2005, at 18:19:33
In reply to Gepirone Positive Studies, posted by Jameswarnica on July 1, 2005, at 17:35:02
I agree with James. Gepirone is not an adjunct therapy--it's a monotherapy. I've been following this medicine for some time and these studies only further support my impressions of gepirone, especially when compared to the SSRIs.
First, the studies show that Gepirone does not cause or worsen sexual dysfuntion. On the otherhand, the literature shows that between 39% and 70% of patients on SSRIs suffer increased sexual dysfunction problems. What makes this ironic is that many depressed patients, as either a cause or effect of the depression, suffer from sexual dysfunction. This is also one of the reasons patients have stopped taking SSRIs--and, then the depression relapses.
Second, patients on Gepirone appear to have a decrease in anxiety-even during the first two weeks. On the otherhand, SSRIs appear to cause an increased anxiety during the first two weeks--I'm curious if this is one of the reasons that people have problems with the SSRIs early in their treatment.
Third, patients on Gepirone show improvement after just two weeks according to the latest studies. SSRIs, I believe, generally take up to 4 weeks.
These are just a few of the reasons I see Gepirone as a monotherapy. Hopefully this medicine will come to market.
poster:Francis
thread:522084
URL: http://www.dr-bob.org/babble/20050708/msgs/525108.html